Product Information
DILTIAZEM 12HR ER 60 MG CAP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.4266 per EA under NDC 50742056401. Its NADAC has been published 44 times since Dec 3, 2025.
FDA first approved this application on Jul 2, 2025. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742056401
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218032FDA Approved
7/2/2025
TE Code
AB1
On Market Since
7/3/2025
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 12HR ER 60 MG CAP has been published 44 times since Dec 3, 2025, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4266 per EA |
|---|---|
| All-time high | $1.7362 (Feb 11, 2026) |
| All-time low | $1.3744 (Apr 22, 2026) |
| 52-week high | $1.7362 |
| 52-week low | $1.3744 |
| Median price | $1.5315 |
| Average price | $1.5279 |
| Largest weekly change | -11.6% (Apr 22, 2026) |
| Weeks tracked | 44 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 12HR ER 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 60 MG CAP, manufactured by Ingenus Pharmaceuticals LLC, is $1.4266 per EA (NDC 50742056401), effective Sep 30, 2026.
How has the price of DILTIAZEM 12HR ER 60 MG CAP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 60 MG CAP has declined 4.8%. It has been tracked across 44 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 60 MG CAP?
Since Dec 3, 2025, the NADAC for DILTIAZEM 12HR ER 60 MG CAP has ranged from a low of $1.3744 (Apr 22, 2026) to a high of $1.7362 (Feb 11, 2026), with a median of $1.5315 per EA.
Are there cheaper alternatives to DILTIAZEM 12HR ER 60 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 12HR ER 60 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DILTIAZEM 12HR ER 60 MG CAP?
DILTIAZEM 12HR ER 60 MG CAP (NDC 50742056401) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.